476 related articles for article (PubMed ID: 17026484)
1. Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.
Correia ML; Rahmouni K
Diabetes Obes Metab; 2006 Nov; 8(6):603-10. PubMed ID: 17026484
[TBL] [Abstract][Full Text] [Related]
2. Obesity, metabolic syndrome and sleep apnoea: all pro-inflammatory states.
Alam I; Lewis K; Stephens JW; Baxter JN
Obes Rev; 2007 Mar; 8(2):119-27. PubMed ID: 17300278
[TBL] [Abstract][Full Text] [Related]
3. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
[TBL] [Abstract][Full Text] [Related]
4. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
Chapman MJ; Sposito AC
Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
[TBL] [Abstract][Full Text] [Related]
5. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
[TBL] [Abstract][Full Text] [Related]
6. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
Chalmers L; Kaskel FJ; Bamgbola O
Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
[TBL] [Abstract][Full Text] [Related]
7. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.
Blaj S; Stanciu S; Jurcut C; Ciobîcă L
Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495
[TBL] [Abstract][Full Text] [Related]
8. Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome.
Odrowaz-Sypniewska G
Adv Med Sci; 2007; 52():246-50. PubMed ID: 18217426
[TBL] [Abstract][Full Text] [Related]
9. Beyond obesity: the diagnosis and pathophysiology of metabolic syndrome.
Gade W; Schmit J; Collins M; Gade J
Clin Lab Sci; 2010; 23(1):51-61; quiz 62-5. PubMed ID: 20218095
[TBL] [Abstract][Full Text] [Related]
10. Obesity and the metabolic syndrome.
Vega GL
Minerva Endocrinol; 2004 Jun; 29(2):47-54. PubMed ID: 15257255
[TBL] [Abstract][Full Text] [Related]
11. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
Reddy KJ; Singh M; Bangit JR; Batsell RR
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance (metabolic) syndrome in children.
Rosenberg B; Moran A; Sinaiko AR
Panminerva Med; 2005 Dec; 47(4):229-44. PubMed ID: 16489322
[TBL] [Abstract][Full Text] [Related]
13. Effect of abdominal obesity on insulin resistance and the components of the metabolic syndrome: evidence supporting obesity as the central feature.
Türkoglu C; Duman BS; Günay D; Cagatay P; Ozcan R; Büyükdevrim AS
Obes Surg; 2003 Oct; 13(5):699-705. PubMed ID: 14627463
[TBL] [Abstract][Full Text] [Related]
14. Adipokines in diabetes and cardiovascular diseases.
Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M
Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155
[TBL] [Abstract][Full Text] [Related]
15. [Leptinemia in individuals with hypertension (pilot study)].
Stejskal D; Růzicka V; Horalík D; Jedelský L; Bartek J; Oral I
Vnitr Lek; 1999 Apr; 45(4):206-9. PubMed ID: 11045180
[TBL] [Abstract][Full Text] [Related]
16. The deadly quartet--the insulin resistance syndrome.
Opara JU; Levine JH
South Med J; 1997 Dec; 90(12):1162-8. PubMed ID: 9404899
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiologic principles of metabolic syndrome. Consequences for early diagnosis and prevention].
Häring HU
Fortschr Med; 1992 Dec; 110(34):633-6. PubMed ID: 1483614
[TBL] [Abstract][Full Text] [Related]
18. Resistance to acute NO-mimetic and EDHF-mimetic effects of leptin in the metabolic syndrome.
Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A; Marciniak A
Life Sci; 2009 Oct; 85(15-16):557-67. PubMed ID: 19686764
[TBL] [Abstract][Full Text] [Related]
19. [Leptin and its association with obesity and type 2 diabetes].
Almanza-Pérez JC; Blancas-Flores G; García-Macedo R; Alarcón-Aguilar FJ; Cruz M
Gac Med Mex; 2008; 144(6):535-42. PubMed ID: 19112726
[TBL] [Abstract][Full Text] [Related]
20. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid.
Lin JD; Chiou WK; Chang HY; Liu FH; Weng HF
Metabolism; 2007 Jun; 56(6):751-6. PubMed ID: 17512306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
